Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi Arabia

Figures & data

Table 1 Demographics and Clinical Characteristics of COVID-19 Survived and Non-Survived Participants

	Survived	Non-Survived
Age [mean (SD)]	53.5 (10.8)	57.9 (12.2)
Gender
Male [n (%)]	42 (38.89)	44 (40.74)
Female [n (%)]	12 (11.11)	10 (9.26)
Length of hospital stay [days, IQR]	10 (5, 15)	9 (7, 14)
Admission to ICU [n (%)]	31 (56.6%)	52 (96.4%)
Length of ICU stay [days, IQR]	5 (0–11.75)	7 (4.25, 12)

Table 2 Hematological Parameters Among COVID-19 Survived and Non-Survived Participants (Values in Parentheses in the First Column Represent Normal Range)

Parameter	Survived	Non-Survived	p-value
RBC (4.15–5.15 x10^12/L)	4.56 (4.02, 5.11)	4.23 (3.75, 4.52)	0.0011
HGB (12.5–16 gm/dl)	13.3 (11.2, 14.35)	12.7 (11.45, 13.55)	0.3704
HCT (38–48%)	39.05 (34.90, 42.55)	37.95 (34.28, 40.50)	0.1767
WBC (4–10 x10^9/L)	10.2 (7.4, 16.7)	8.5 (6.1, 11.7)	0.0477
Neutrophils (40–80%)	83.9 (72.7, 89.3)	81 (73.9, 84)	0.0929
Lymphocytes (20–40%)	9.4 (5.1, 14.7)	11 (8, 14.8)	0.487
Monocytes (2–10%)	5 (2.9, 8.5)	5.7 (4, 7)	0.1649
Eosinophils (1–6%)	0.40 (0.01, 1.67)	0.15 (0.02, 0.68)	0.2008
Basophils (1–2%)	0.20 (0.10, 0.30)	0.09 (0.02, 0.19)	0.0047
Platelet (150–410 x10^9/L)	266.1±132.5	248±95.7	0.4164
PT (10.4–12.6 seconds)	12.5 (11.7, 13.4)	14 (13.6, 15)	<0.0001
PTT (25.9–36.6 seconds)	31.8 (28, 39.2)	40 (36.9, 44.4)	0.0008
Serum Ferritin (20–250 ng/mL)	874 (636.2, 1536.3)	1560 (838, 2524)	0.1767

Figure 1 Correlation between Lymphocytes Percentage and Duration of Hospital and Intensive Care Unit (ICU) Stay among Survived (A and C) and Non-survived (B and D) COVID-19 Patients.